Chemoinformaics analysis of cis-3-Hexenyl formate
Molecular Weight | 128.171 | nRot | 5 |
Heavy Atom Molecular Weight | 116.075 | nRig | 2 |
Exact Molecular Weight | 128.084 | nRing | 0 |
Solubility: LogS | -2.247 | nHRing | 0 |
Solubility: LogP | 1.205 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 21.2955 |
nHD | 0 | BPOL | 14.6425 |
QED | 0.319 |
Synth | 3.067 |
Natural Product Likeliness | 1.957 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.007 |
HIA | 0.008 |
CACO-2 | -4.646 |
MDCK | 0.000180397 |
BBB | 0.996 |
PPB | 0.346976 |
VDSS | 1.012 |
FU | 0.579569 |
CYP1A2-inh | 0.848 |
CYP1A2-sub | 0.768 |
CYP2c19-inh | 0.323 |
CYP2c19-sub | 0.748 |
CYP2c9-inh | 0.039 |
CYP2c9-sub | 0.705 |
CYP2d6-inh | 0.134 |
CYP2d6-sub | 0.836 |
CYP3a4-inh | 0.04 |
CYP3a4-sub | 0.224 |
CL | 7.049 |
T12 | 0.928 |
hERG | 0.013 |
Ames | 0.028 |
ROA | 0.023 |
SkinSen | 0.803 |
Carcinogencity | 0.828 |
EI | 0.948 |
Respiratory | 0.174 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.950486 |